Unknown

Dataset Information

0

Avapritinib for Cutaneous Mastocytosis.

ABSTRACT:

SUBMITTER: Lee H 

PROVIDER: S-EPMC9309867 | biostudies-literature | 2021 Jan

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Avapritinib for Cutaneous Mastocytosis.

Lee Hannah H   Li Tian T   Wisell Joshua J   Schowinsky Jeffrey J   Robinson William A WA  

Acta dermato-venereologica 20210105 1

Similar Datasets

Unknown Clonal dynamics of aggressive systemic mastocytosis on avapritinib therapy.
| S-EPMC11473837 | biostudies-literature
Unknown Liver fibrosis and its response to avapritinib in 2 patients with systemic mastocytosis.
| S-EPMC9647789 | biostudies-literature
Unknown Efficacy and safety of avapritinib in previously treated patients with advanced systemic mastocytosis.
| S-EPMC9647833 | biostudies-literature
Unknown Efficacy of avapritinib versus best available therapy in the treatment of advanced systemic mastocytosis.
| S-EPMC9343245 | biostudies-literature
Unknown Safety and efficacy of avapritinib in advanced systemic mastocytosis: the phase 1 EXPLORER trial.
| S-EPMC8674134 | biostudies-literature
Unknown P1014: OVERALL SURVIVAL IN PATIENTS WITH ADVANCED SYSTEMIC MASTOCYTOSIS RECEIVING AVAPRITINIB VERSUS MIDOSTAURIN OR CLADRIBINE
| S-EPMC9429350 | biostudies-literature
Unknown Correlates of organ damage in patients with advanced systemic mastocytosis enrolled in clinical trials of avapritinib.
| S-EPMC12711656 | biostudies-literature
Unknown Efficacy and safety of avapritinib in advanced systemic mastocytosis: interim analysis of the phase 2 PATHFINDER trial.
| S-EPMC8674139 | biostudies-literature
Unknown Cutaneous and splenic mastocytosis in a juvenile Malayan tiger.
| S-EPMC8921805 | biostudies-literature
Unknown Inhibitory effects of midostaurin and avapritinib on myeloid progenitors derived from patients with KIT D816V positive advanced systemic mastocytosis.
| S-EPMC6756065 | biostudies-literature